A4L Expands into JLABS @ Toronto
TORONTO, ON – Jan. 16, 2017 – Today, Analytics 4 Life (A4L), a machine intelligence company developing noninvasive, cost-effective medical devices, announced its expansion into JLABS @ Toronto, one of Johnson & Johnson Innovation’s life science incubators. As a resident in the space, A4L has access to a rich ecosystem of cardiovascular medical device development and commercialization expertise.
JLABS @ Toronto is a life science innovation center that provides a flexible environment for start-up companies pursuing new technologies and research platforms to advance medical care. Through a “no strings attached” model, Johnson & Johnson Innovation does not take an equity stake in the companies occupying JLABS and the companies are free to develop products—either on their own, or by initiating a separate external partnership with Johnson & Johnson Innovation or any other company.
“This is a unique opportunity for A4L to leverage the mentorship of the organization and the JLABS infrastructure that will be beneficial to developing machine-learned solutions,” says Ian Shadforth, Chief Technology Officer at A4L. “We are very excited to locate our medical device product development team here as we continue rapid advancement of our initial product, CorVista™, through clinical trials.” Last year, A4L announced its participation in the IBM Innovation Space, where its Agilytics™ machine learning platform development team is housed.
In May 2016, A4L launched its multi-center Coronary Artery Disease Learning and Algorithm Development (CADLAD) clinical study that will enroll up to 2,500 subjects from up to 25 medical centers within the United States. “This is a two-stage study where we will first develop our machine-learned algorithm for detecting CAD using paired physiologic signals and clinical outcomes data. Then, we will subsequently test that algorithm in a prospective, blinded, non-randomized, paired comparison trial,” says Dr. Williams Sanders, Chief Medical Officer, “In March, we will be presenting preliminary results of our work at the American College of Cardiology (ACC) conference.”
CorVista is a non-invasive medical imaging system that is designed to acquire and process patient data and display results in a report accessible via a secure web portal. The system scans signals emitted by the body without radiation, exercise, or pharmacologic stress and wirelessly transmits the signal package to the cloud for processing and report generation. Physicians can interpret and use the results as part of an assessment of their patient. CorVista is an investigational device limited by federal law to investigational use. CorVista is not available for commercial distribution.
About Analytics 4 Life®
Analytics 4 Life is pioneering digital health using artificial intelligence to develop a completely new cardiac diagnostic modality. With an initial focus on coronary artery disease, heart failure, and pulmonary hypertension, Analytics 4 Life is advancing a novel, radiation-free, and exercise-free cardiac diagnostic platform aimed at improving existing care pathways. Analytics 4 Life is based in Toronto with U.S. headquarters in Research Triangle Park, NC. For more information, visit www.staging.analytics4life.com.
Analytics 4 Life
SOURCE: PR Newswire